Access Restricted for EU Residents
You are attempting to access a website operated by an entity not regulated in the EU. Products and services on this website do not comply with EU laws or ESMA investor-protection standards.
As an EU resident, you cannot proceed to the offshore website.
Please continue on the EU-regulated website to ensure full regulatory protection.
Wednesday Jul 22 2026 03:17
14 min

IBM earnings are back in focus as investors await the company's full second-quarter 2026 financial results, due after the U.S. market closes on July 22. The upcoming report follows a surprise preliminary earnings release on July 14 that fell well short of Wall Street expectations, triggering IBM's largest single-day stock decline in more than six decades.
While the market already has an early look at the company's headline numbers, investors are now looking for answers on IBM's full-year outlook, the health of its software business, and whether artificial intelligence (AI) investments can offset growing concerns over slowing enterprise spending.
IBM shocked investors earlier this month when it released preliminary second-quarter results ahead of schedule, revealing weaker-than-expected revenue growth despite continued investment in AI and hybrid cloud technologies.
The company reported preliminary second-quarter revenue of $17.2 billion, missing analysts' expectations of approximately $17.9 billion. Non-GAAP earnings per share came in at $2.93, below the market consensus of around $3.01, although GAAP EPS of $2.27 slightly exceeded forecasts.
Net income attributable to shareholders declined roughly 4.5% year over year to $2.48 billion, while total revenue increased just 1% from a year earlier—well below the company's previous full-year target of more than 5% constant-currency revenue growth.
The disappointing update immediately raised questions about IBM's ability to sustain its AI-driven growth strategy in an increasingly competitive enterprise technology market.
Metric | Q2 Preliminary Data | Market Consensus | Variance / Notes |
|---|---|---|---|
Revenue | $17.2 Billion | ~$17.9 Billion | Below consensus by ~$700M |
GAAP EPS | $2.27 | $2.168 | Slightly beat consensus |
Non-GAAP EPS | $2.93 | ~$3.01 - $3.02 | Below consensus |
Net Income (Attributable) | $2.479 Billion | — | Down 4.5% YoY |
The biggest concern heading into the full earnings release remains IBM's uneven business performance across its operating segments.
Software revenue continued to grow, rising approximately 5%, but the pace was significantly below management's long-term target of around 10%. Within the software portfolio, Red Hat remained a bright spot, accelerating to 11% growth, while recently acquired businesses including HashiCorp and Confluent also delivered strong performance.
IBM's consulting business remained largely flat, posting modest constant-currency growth of around 1%. Although demand for generative AI consulting services continued to increase, broader enterprise consulting activity remained subdued.
The largest disappointment came from IBM's infrastructure segment, where revenue fell approximately 7%, substantially worse than management's previous expectation for only a modest decline. Weakness in IBM's mainframe business and transaction processing software weighed heavily on overall performance, although distributed infrastructure solutions posted record growth.
The sharp slowdown has led some analysts to question whether IBM's traditional infrastructure business is facing deeper structural challenges.
Chief Executive Officer Arvind Krishna acknowledged that IBM underperformed expectations during the quarter, pointing to several factors behind the disappointing results.
According to management, many enterprise customers shifted capital spending toward AI infrastructure, including servers, storage systems, and high-performance memory components, particularly during the final weeks of the quarter. Companies rushed to secure hardware supply before anticipated price increases, leaving fewer budget dollars available for software and consulting projects.
IBM also cited delays in closing several large enterprise contracts, with management admitting that sales execution did not keep pace with rapidly changing customer purchasing behavior.
At the same time, heightened cybersecurity concerns caused some enterprise clients to postpone purchasing decisions, further extending sales cycles across multiple business lines.
Together, these trends suggest that the current AI investment cycle may be temporarily benefiting hardware suppliers at the expense of traditional software and enterprise services providers.
Investors responded swiftly to the preliminary earnings announcement.
IBM shares plunged approximately 25% on July 14, marking the company's largest single-day decline since 1961 and wiping out nearly $69 billion in market value.
Although the stock has stabilized around $210 ahead of the official earnings release, technical indicators continue to reflect significant weakness. Shares remain well below their 20-day, 50-day, and 200-day moving averages, while momentum indicators including RSI and KDJ suggest the stock has entered deeply oversold territory.
Despite the sharp correction, Wall Street remains divided on IBM's longer-term outlook.
Several investment banks lowered their price targets following the preliminary earnings announcement. Bank of America reduced its target to $280, RBC Capital Markets lowered its target to $270, while HSBC maintained one of the Street's most cautious views with a $191 target. Meanwhile, firms including Goldman Sachs and Citi continue to maintain more constructive long-term ratings, citing IBM's strategic AI initiatives.
Institution | Rating | Adjusted Target Price | Previous Target Price |
|---|---|---|---|
BofA Securities | Buy | $280 | $330 |
RBC Capital | Outperform | $270 | $300 |
Citi | Buy | $375 | — |
Goldman Sachs | Buy | $335 | — |
HSBC | Sell | $191 | — |
Morgan Stanley | Hold | $293 | — |
Following the sell-off, IBM's valuation has become considerably less demanding.
The company currently trades at roughly 18.4 times trailing earnings, well below the broader technology industry's average valuation of around 26 times. Its price-to-cash-flow multiple has also fallen below sector averages, suggesting much of the near-term disappointment may already be reflected in the share price.
For value-oriented investors, the lower valuation could provide support if IBM demonstrates that recent weakness is temporary rather than structural.
Despite the disappointing quarter, IBM continues to make progress across several strategic growth initiatives.
Red Hat remains one of the company's strongest growth engines as enterprises continue adopting hybrid cloud infrastructure. IBM also reaffirmed its long-term commitment to quantum computing, with plans to invest more than $10 billion over the next five years and deliver a large-scale fault-tolerant quantum computer before the end of the decade.
The company has also expanded its cybersecurity offerings through its Lightwell platform while benefiting from recent acquisitions that continue to contribute positively to software revenue.
Meanwhile, IBM generated approximately $4.8 billion in free cash flow during the first half of the year, providing financial flexibility for continued investment, acquisitions, and shareholder returns.
Although investors already know the preliminary financial results, the full earnings release could still serve as an important catalyst for IBM shares.
Markets will be closely watching whether management lowers its full-year revenue guidance after second-quarter growth slowed to just 1%. Investors also want greater clarity on whether delayed enterprise deals are expected to close later this year or represent permanently lost business.
Updates on Red Hat's growth trajectory, enterprise AI demand, consulting trends, and customer spending patterns will all help investors assess whether IBM's recent weakness reflects a short-term execution issue or a broader shift in enterprise technology spending.
Management commentary on AI monetization, hybrid cloud adoption, and quantum computing strategy may ultimately prove more important than the reported financial results themselves.
Risk Warning: This article is provided for informational purposes only and does not constitute investment advice, investment research, or a recommendation to trade. The views expressed are those of the author and do not necessarily reflect the position of Markets.com. When considering shares, indices, forex (foreign exchange), and commodities for trading and price predictions, remember that trading CFDs involves a significant degree of risk and may not be suitable for all investors. Leveraged products can result in capital loss. Past performance is not indicative of future results. Before trading, ensure you fully understand the risks involved and consider your investment objectives and level of experience. Cryptocurrency CFD trading restrictions may apply depending on jurisdiction.